ANDREA OLSON: Open Payments
NPI 1316304769 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,388 in 31 payments from 8 companies in 2025. Trend: 2023 $4,298 · 2024 $2,912 · 2025 $3,388
Speaker / faculty: $2,700Food & beverage: $688
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $2,965 |
| Alnylam Pharmaceuticals Inc. | 7 | $156 |
| Novartis Pharmaceuticals Corporation | 7 | $138 |
| E.R. Squibb & Sons, L.L.C. | 3 | $44 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| PFIZER INC. | 1 | $21 |
| Novo Nordisk Inc | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: Repatha, ONPATTRO, LEQVIO, CAMZYOS, VERQUVO, ENTRESTO, VYNDAQEL, Wegovy.
Industry payments across SC — which companies pay providers there.
